Sensex
73,049.58 profit arw -269.97 (-0.37%)
Nifty
22,613.95 profit arw -99.15 (-0.44%)
Nasdaq
18,355.20 profit arw -497.09 (-2.64%)
logo img

GET IN TOUCH

GET IN TOUCH

Refresh Captcha
Equity

As on : 06-Apr-2026
Corporate News
06-Apr-2026     09:05

Aurobindo Pharma approves transfer of its generic formations products biz to Auropharm

The board of Aurobindo Pharma at its meeting held on 06 April 2026 has approved the transfer of the Company's domestic branded generic pharmaceutical formulations products business on a going concern basis through a Business Transfer Agreement (BTA) to Auropharm (previously known as Auro Pharma), a wholly owned subsidiary of the Company. It is in line with the Company's strategy in further streamlining and accelerating Company's domestic business for faster growth.

INDIAN INDICES

Sensex

73,049.58 -269.97 (-0.37%)

Nifty

22,613.95 -99.15 (-0.44%)

GLOBAL INDICES

USD

NA

NASDAQ
HANG SENG

25,116.54 -177.50(-0.70%)